Definitive Contract HHSN268201200052C
Award Date 9/20/12
Potential Completion Date 8/15/16
Potential Value $187K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Madison, WI 53707, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Wicell Research Institute, Inc., a non-profit organization, by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services. The contract, valued at $16,137,048.00, is for the provision of human pluripotent stem cell lines, testing, and related services to support biomedical research. Wicell is a global leader in stem cell banking and distribution, and has provided specific cell lines to the National Institutes...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to the non-profit Wicell Research Institute, Inc. for services related to the karyotype analysis and fluorescence in situ hybridization (FISH) testing of human cell lines. The $17,178.50 contract is for the delivery of these specific testing and analysis services on human pluripotent stem cell lines to support biomedical research...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies. The contract, valued at...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence. The $4,828.50 firm fixed-price contract was issued as a Blanket Purchase Agreement (BPA) call, without any set-aside designation. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The prime contractor is STEMCELL TECHNOLOGIES INC, a foreign-owned, for-profit biotechnology company headquartered in Canada, with a registered entity in the United States. The $11,882.50 firm fixed-price contract is a BPA (Blanket Purchase Agreement) call, not a set-aside. It supports the agency's biomedical research mission by...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price contract valued at $18,120.00 to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of May 18, 2025. The purpose of the contract is to provide cell purification kits to the NHLBI LEONARD LAB in order to purify...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), an agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence in Kent, Washington. The $20,964 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of December 31, 2017. The contract is not set aside for any specific business type....
- This federal contract award, valued at $75,650.00, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to STEMCELL Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The contract is a firm fixed-price purchase order with no small business set-aside designation. The award supports the NHLBI's biomedical research activities by providing specialized biological...
- This federal contract award from the National Human Genome Research Institute, an agency within the U.S. Department of Health and Human Services, was made to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract, valued at $425,000.00, is for the generation of 50 induced pluripotent stem cell (iPSC) lines from fusion study fibroblast cell lines. No set-aside designation was used for this contract. The New York Stem Cell Foundation Inc....
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. entity in Kent, Washington. The $6,528 firm-fixed-price contract was awarded on March 16, 2015 as a Blanket Purchase Agreement (BPA) call, with a completion date of May 31, 2015. Stemcell Technologies Inc. was not awarded...